Table 3. Metabolic Inhibitor-Induced Changes in Redox Ratios of Quiescent and Activated T cells ^a .

Definition Method	$\frac{FAD}{NAD(P)H}$		$\frac{NAD(P)H}{FAD+NAD(P)H}$		$\frac{FAD}{FAD+NAD(P)H}$		$\frac{NAD(P)H{\alpha }_2}{FAD{\alpha }_1}$
Activation Status	A	Q	A	Q	A	Q	A	Q
Rotenone + Antimycin A	—	↓	—	↑	—	↓	↓	↓
2DG	↑	↓	↓	↑	↑	↓	↓	—
TOFA	—	↓	—	↑	—	↓	↓	↓
BPTES	↑	—	↓	↑	↑	↓	↓	↓

^a2DG: 2-deoxy-d-glucose, TOFA: 5-(Tetradecyloxy)-2-furoic acid, BPTES: Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl) ethyl sulfide; A: Activated; Q: Quiescent. FLIRR trends inconsistent with intensity-based redox ratios denoted with shading.